Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
Conditions
- Primary Peritoneal Cavity Cancer
- Recurrent Ovarian Epithelial Cancer
Interventions
- DRUG: lapatinib ditosylate
- OTHER: laboratory biomarker analysis
Sponsor
National Cancer Institute (NCI)
Collaborators